# Lacosamide Intravenous Injection for Emergency Termination of Status Epilepticus

> **NCT06966830** · — · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital of Guangzhou Medical University** · enrollment: 100 (estimated)

## Conditions studied

- Epilepsy
- Status Epilepticus

## Interventions

- **DRUG:** Lacosamide (LCM)

## Key facts

- **NCT ID:** NCT06966830
- **Lead sponsor:** Second Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-06
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-10-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-05-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06966830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06966830, "Lacosamide Intravenous Injection for Emergency Termination of Status Epilepticus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06966830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*